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ABSTRACT | Purpose: To evaluate causes and management of 
congenital corneal opacities (CCO) diagnosed in a tertiary care 
eye center and to compare the data with a previous study at the 
same institution. Methods: Computerized medical records in 
all patients with congenital corneal opacities diagnosed in the 
Cornea Service at Wills Eye Hospital (Philadelphia, PA) between 
January 1, 2007, and December 31, 2015, were retrospectively 
reviewed. Children aged 12 years and younger at the first visit 
were included in the study. Patients’ demographics, ocular 
diagnosis, laterality, associated ocular abnormalities, other 
ocular surgery performed prior or subsequent to the first visit, 
and their treatment were extracted from the medical records. 
Results: A total of 77 eyes in 56 patients were examined. The 
mean age at presentation was 32.8 ± 44.2 months, with the 
mean follow-up period of 26.7 ± 30.1 months. The most fre-
quent diagnosis was Peters anomaly (53.2%), followed by limbal 
dermoid (13.0%), aniridia with glaucoma and microphthalmos 
(6.5%), sclerocornea and congenital glaucoma (5.2%), idiopathic 
(3.9%), Axenfeld-Rieger anomaly and Hurler syndrome (2.6%), 
and microcornea (1.3%). Primary keratoplasty was performed 
in 26 eyes, with the outcome rate in the clear cornea of 76.0% 
during the follow-up. Conclusion: Peters anomaly is the most 
common cause of congenital corneal opacities encountered at 
our institution. Penetrating keratoplasty is the most frequent 
choice of corneal surgery to treat congenital corneal opacities. 
Additional interventions during penetrating keratoplasty were 
moderately positively correlated with graft failure. This study 
also shows the rates of some etiologies of that changed over the 
recent decades in our tertiary care Cornea Service. Although 
Peters anomaly remains the most common presenting reason for 
congenital corneal opacities, its rate appears to be increasing 
over the recent decade. Congenital corneal opacities due to birth 
trauma, which is one of the preventable causes, were observed 
in a previous study in our clinic; however, no new cases were 
noted in this study.
Keywords: Cornea/abnormalites; Corneal opacity/congenital; 
Keratoplasty, penetrating; Peters anomaly; Tertiary healthcare
RESUMO | Objetivo: Avaliar as causas e o controle das opa-
cidades corneanas congênitas diagnosticadas em um centro 
oftal mológico de atendimento terciário e comparar os dados com 
um estudo anterior realizado na mesma instituição. Métodos: 
Prontuários médicos informatizados de todos os pacientes com 
opacidade corneana congênita diagnosticada no Serviço 
de Córnea no Wills Eye Hospital (Filadélfia, PA) entre 1º de 
ja neiro de 2007 e 31 de dezembro de 2015 foram revisados 
retrospectivamente. Crianças com 12 anos ou menos na primeira 
consulta foram incluídas no estudo. A demografia dos pacientes, 
o diagnóstico ocular, a lateralidade, as anormalidades oculares 
associadas, outras cirurgias oculares realizadas antes ou após a 
primeira consulta e o tratamento foram extraídos dos prontuários 
médicos. Resultados: Um total de 77 olhos de 56 pacientes foi 
examinado. A idade média de apresentação foi de 32,8 ± 44,2 
meses, com um tempo médio de acompanhamento de 26,7 
± 30,1 meses. O diagnóstico mais frequente foi anomalia de 
Peters (53,2%), seguido por dermóide límbico (13,0%), aniridia 
com glaucoma e microftalmia (6,5%), esclerocórnea e glaucoma 
congênito (5,2%), idiopático (3,9%), síndrome de Axenfeld-Rieger 
e síndrome de Hurler (2,6%) e microcórnea (1,3%). Ceratoplastia 
primária foi realizada em 26 olhos, com desfecho de córnea clara 
de 76,0% durante o acompanhamento. Conclusão: A anomalia 
de Peters é a causa mais comum de opacidade corneana congênita 
encontrada em nossa instituição. A ceratoplastia penetrante é a 
escolha mais frequente de cirurgia corneana para o tratamento 
de opacidades corneanas congênitas. Intervenções adicionais 
durante a ceratoplastia penetrante foram moderadamente 
correlacionadas positivamente com a falha do enxerto. Este 
estudo também mostra as taxas de algumas etiologias do que 
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mudou ao longo faz últimas décadas em nosso serviço de córnea 
de atendimento terciário. Embora a anomalia de Peters continue 
a ser a causa mais comum das opacidades congênitas da córnea, 
sua taxa parece estar aumentando na última década. Opacidades 
congênitas da córnea devido a trauma no nascimento, que é uma 
das causas evitáveis, foram observadas em um estudo anterior 
em nossa clínica; no entanto, nenhum caso novo foi observado 
neste estudo.
Descritores: Córnea/anormalidades; Opacidade da córnea/
con gênito; Ceratoplastia penetrante; Atenção terciária à saúde
INTRODUCTION
Congenital corneal opacities (CCO) are defined as a 
group of diseases characterized by loss of transparency 
in the corneal tissue at birth or during the first 4 weeks 
of life(1,2). Etiologic factors affecting the anterior seg-
ment differentiation between the 6th and 16th weeks of 
gestation are responsible for most CCOs. These factors 
may be infectious, genetic, metabolic, developmental, 
traumatic, toxic, idiopathic, or a combination of these(1,2). 
Most cases are bilateral and are often observed with other 
ocular malformations. They may also be accompanied by 
complex systemic disorders. CCO incidence is reported 
from 2.2 to 3.11 per 100,000 births(3-5). Although CCO 
is a rare entity, prompt diagnosis and treatment are very 
important due to the high risk of amblyopia and possi-
bility of lifelong visual impairment in bilateral cases(3,4). 
Its diagnosis, treatment, and follow-up were associated 
with their own set of difficulties(1-4).
This study aimed to analyze the data (patients’ demo-
graphics, ocular diagnosis, laterality, associated ocular 
abnormalities, other ocular surgery performed prior or 
subsequent to the first visit, and the treatment) of CCO 
children diagnosed in the Cornea Service at Wills Eye 
Hospital between January 2007 and December 2015 and 
compare the results with another study also conducted 
in our Service a decade prior as well as other studies in 
the literature.
METHODS
Computerized medical records of all patients with 
CCO diagnosed in the Cornea Service at Wills Eye Hos-
pital (Philadelphia, PA) between January 1, 2007, and 
December 31, 2015, were retrospectively reviewed. Pa-
tients were identified through a computerized diagnosis 
code search. Children aged 12 years and younger at their 
first visit to our Cornea Service were included in the 
study. Patients with eyes that underwent previous cor-
neal surgery in another hospital were excluded. Patients’ 
de mographics, ocular diagnosis, laterality, associated 
ocular abnormalities, other ocular surgeries performed 
prior or subsequent to the first visit, and the treatment 
and surgical outcomes were extracted from medical 
records. This study protocol was approved by the Wills 
Eye Hospital Institutional Review Board and conducted 
in accordance with the Declaration of Helsinki.
The SPSS software version 16 (SPSS Inc., Chicago, 
IL, USA) were used for statistical analyses. The Kolmo-
gorov-Smirnov test was used to investigate variables in 
order to determine whether or not they are normally 
distributed. Descriptive statistical methods (mean, stan-
dard deviation, median, frequency, ratio, minimum, and 
maximum) were used to evaluate this study’s data. The 
Spearman’s correlation test was used to evaluate the 
data. P-values of <0.05 were considered statistically 
significant.
RESULTS
A total of 96 eyes in 64 patients (32 unilateral, 32 
bilateral) with CCO were identified from the medical 
records. After excluding 19 eyes that had corneal 
surgery prior to the first visit at Wills, 77 eyes in 56 
patients were included in the analysis. Among them, 30 
(53.6%) were females and 26 (46.4%) were males. Both 
eyes were diagnosed with CCO in 21 patients (38%). 
The mean age at presentation was 32.9 ± 44.2 (range, 
0.2-144) months, with the mean follow-up period of 
26.7 ± 30.1 (range 0.1-103) months. The most frequent 
diagnosis was Peters anomaly (41 eyes, 53.2%), follo-
wed by limbal dermoid (13.0%), aniridia with glaucoma 
(6.5%), microphthalmos (6.5%), sclerocornea (5.2%), 
congenital glaucoma (5.2%), idiopathic corneal opacity 
(3.9%), Axenfeld-Rieger anomaly (2.6%), Hurler syndro-
me (2.6%), and microcornea (1.3%) (Table 1). Corneal 
findings in all eyes at presentation are presented in table 2. 
Corneal findings in eyes with Peters anomaly are shown 
in table 3. The most common findings were central haze/
scar (27 eyes, 65.9%), paracentral haze/scar (12.2%), 
edema (9.7%), and pannus (9.7%). Thirty eyes (39.0%) 
underwent corneal surgery, which included penetrating 
keratoplasty in 25 eyes (32.5%), limbal dermoid excision 
in 3 (3.9%), keratoprosthesis in 1 (1.3%), and lamellar 
keratectomy in 1 (1.3%) (Table 4).
Patients’ diagnoses are summarized in table 5.
Ocular surgery, other than corneal surgery, was 
performed in 16 eyes prior to the first visit at Wills. 
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Table 1. Diagnosis for congenital corneal opacity
Diagnosis Number of eyes %
Peters anomaly 41 53.2
Limbal dermoid 10 13.0
Aniridia with glaucoma 5 6.5
Microphthalmos 5 6.5
Sclerocornea 4 5.2
Congenital glaucoma 4 5.2
Idiopathic corneal opacity 3 3.9
Axenfeld-Rieger Anomaly 2 2.6
Hurler syndrome 2 2.6
Microcornea 1 1.3
Table 2. Presenting timely corneal findings
Corneal findings Number of eyes %
Central haze/scar 37 48,1
Diffuse full thickness haze 13 16.9
Corneal mass 9 11.7
Neovascularization/pannus 11 14.3
Paracentral/peripheral haze/scar 12 15.6
Edema 8 10.4
Microcornea 5 6.5
Band keratopathy 4 5.2
Scleralization 4 5.2
Buphthalmos 5 6.5
Posterior embryotoxon 5 6.5
Posterior keratoconus 1 1.3
*More than one finding may occur in the same eye.
Table 3. Corneal findings in 41 eyes with Peters anomaly
Corneal findings Number of eyes (n) %
Central haze/scar 27 65.9
Paracentral haze/scar 5 12.2
Edema 4 9.7
Pannus 4 9.7
Posterior embryotoxon 3 7.3
Band keratopathy 3 7.3
Neovascularization 3 7.3
Diffuse full thickness haze 3 7.3
Peripheral haze/scar 2 4.9
Indistinct limbus 2 4.9
Microcornea 1 2.4
Posterior keratoconus 1 2.4
*More than one findings may occur in the same eye.
Table 4. Surgeries performed prior to presentation, corneal surgeries 
performed at our institution, and concurrent and subsequent surgeries 
to the corneal surgeries.
Number of eyes* %
Prior to time of presentation
Glaucoma drainage device 4 5.2
Trabeculectomy 4 5.2
Trabeculotomy/goniotomy 2 2.6
Cataract extraction 4 5.2
Phacoemulsification with lens implant 3 3.9
Cyclophotocoagulation 3 3.6
Strabismus surgery 2 2.6
Corneal surgery
Penetrating keratoplasty 25 32.5
Lamellar keratectomy 1 1.3
Primary keratoprosthesis 1 1.3
Limbal dermoid excision 3 3.9
Second penetrating keratoplasty 5 6.5
Keratoprosthesis after penetrating keratoplasty 1 1.3
Third penetrating keratoplasty 2 2.6
Fourth penetrating keratoplasty 1 1.3
Concurrent surgery to corneal surgery
Lensectomy 7 9.1
Anterior vitrectomy 7 9.1
Peripheral iridectomy 12 15.6
Release of synechiae 7 9.1
Cyclophotocoagulation 2 2.6
Amniotic membrane transplantation 2 2.6
Pars plana vitrectomy 1 1.3
Laser retinopexy 1 1.3
Subsequent or additional surgery to corneal surgery
Glaucoma drainage device 2 2.6
Cataract extraction 2 2.6
Strabismus surgery 3 3.9
Pupilloplasty 2 2.6
Phacoemulsification with lens implant 2 2.6
Revision of glaucoma drainage device 1 1.3
*More than one procedure may occur in the same eye.
Table 5. Diagnosing eyes undergoing primary penetrating keratoplasty
Diagnosis Eyes (n) %
Peters anomaly 20 76.9
Aniridia glaucoma 2 7.7
Sclerocornea 2 7.7
Congenital glaucoma 1 3.8
Idiopathic corneal opacity at birth 1 3.8
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Concurrent surgeries were performed in 15 eyes at the 
time of corneal surgery, as shown in table 4. Five of 25 
eyes that underwent penetrating keratoplasty underwent 
a second keratoplasty, and one eye underwent kerato-
prosthesis (four of these six eyes had Peters anomaly 
and the other two eyes had sclerocornea) (24% graft 
failure). Keratoplasties were performed in three eyes, 
and a fourth keratoplasty in one eye. When analyzing 
six eyes with graft failure, four had Peters anomaly (20 
total eyes had Peters anomaly) and two of them had 
sclerocornea (2 total eyes had sclerocornea). The graft 
failure rate was 20% in patients with Peters anomaly 
and 100% in those with sclerocornea.
Glaucoma was observed in 24 eyes (31.2%) prior to 
their first visit or during our follow-up at Wills. Glau-
coma surgeries were performed 13 eyes prior to their 
first visit including four glaucoma drainage devices, four 
trabeculectomies, 3 cyclophotocoagulations, and two tra-
beculotomy/goniotomy procedures. Concurrent glauco-
ma surgeries were performed in two eyes (cyclophoto-
coagulation) at the time of corneal surgery. Additionally, 
subsequent glaucoma surgeries were performed in two 
eyes, and revision of a glaucoma drainage device was 
performed in one eye after a corneal surgery (Table 4). 
Seven of the 24 eyes were followed with medical glau-
coma treatment. The correlation between the presence 
of glaucoma and history of previous surgery before the 
presentation was statistically significantly moderately 
positive (r=0.498, p=0.010). Concurrent intervention 
at the time of primary keratoplasty was statistically mo-
derately correlated with the need for secondary kera-
toplasty (r=0.445, p=0.026). The outcome rate in the 
clear cornea during the follow-up was 76.0%.
DISCUSSION
Patients with CCO are highly at risk of deprivation 
amblyopia since a clear cornea is required for healthy 
vision development. Furthermore, because these con-
ditions are commonly bilateral, patients are highly at 
risk for lifelong visual impairment. Therefore, diagnosis, 
determination of concomitant ocular and systemic pa-
thologies, and treatment of CCO as early as possible are 
essential(1,2,5).
CCO is an etiologically heterogenic situation. Its 
occurrence CCO vary depending on the developmental 
level of the country and genetic and environmental fac-
tors. Only a few studies investigated these conditions(1-5). 
However, most of the information in these studies was 
obtained from pediatric keratoplasty. Not surprisingly, 
the most common reasons for CCO vary between diffe-
rent countries(1-8).
Peters anomaly is found in 40.3% and 72.7% of pa-
tients in two of the largest studies on CCO, the first one 
in the USA(1), in the previous study in our institution, and 
the second one in Japan(2). Sclerocornea is the second 
most common etiology, with the occurrence rate of 18% 
in a US study(1) and anterior staphyloma in a Japanese 
study(2). In the present study, Peters anomaly (53.2%) 
was the most common etiology of CCO, followed by 
limbal dermoid (13.0%), aniridia with glaucoma and 
mi crophthalmos (6.5%), sclerocornea and congenital 
glaucoma (5.2%), idiopathic (3.9%), and Axenfeld-Rieger 
anomaly and Hurler syndrome (2.6%) according to fre-
quency. This study also shows CCO rates that changed 
over the recent decades in our tertiary care Cornea Ser-
vice. In our previous study, the most common primary 
cause of CCO was Peters anomaly (40.3%), followed by 
sclerocornea (18.1%), dermoid (15.3%), congenital glau-
coma and idiopathic (6.9%), microphthalmia (4.2%), and 
birth trauma and metabolic diseases (2.8%). Even though 
Peters anomaly remains the most common etiology of 
CCO, its rate appears to be increasing in the recent 
decade. CCO due to birth trauma, which is one of the 
preventable causes, was observed in 2.8% of patients 
in our clinic’s previous study(1); however, no new case 
was detected in this study. Although idiopathic CCO was 
observed in 6.9% of the patients in our clinic’s previous 
study(1), its rate appears to be decreasing in the recent 
decade (3.9%). Bilateral involvement of CCO was obser-
ved in 73.6% of patients from the Far East,2 55.3% in our 
clinic’s previous study(1), and 54.6% in this study.
In a Saudi Arabian study, Al-Ghamdi et al. reported 
130 patients with primary pediatric keratoplasty had 
CCO. In their cases, the most common etiologies were 
congenital glaucoma (33.7%), congenital hereditary en-
dothelial dystrophy (CHED) (26.9%), and Peters anomaly 
(21.5%)(6). In Patel et al.’s study in New Zealand, nine 
pediatric keratoplasties were performed over a 13-year 
period because of CCO, and 44.7% of them had Peters 
anomaly, followed by CHED (22.2%), idiopathic (22.2%), 
and limbal dermoid (11.1%)(7). In a Finland study, Ma-
jander et al. evaluated 14 eyes of seven patients with 
CCO who underwent anterior segment optic coherence 
tomography. Peters anomaly with the rate of 71.4%, 
congenital corneal staphyloma with 21.4%, and micro-
phthalmos with 7.1% were diagnosed in these eyes(8).
Because the risk of amblyopia and visual impairment 
is high in eyes with CCO, keratoplasty, most frequently 
penetrating keratoplasty, is the most common treatment 
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method(7-10). Penetrating keratoplasty is an especially 
risky procedure in children because their ocular tissues 
continuously grow, scleral flexibility is high, follow up 
is more difficult, and other ocular pathologies are com-
monly present in this age group(8,9). In our study, primary 
penetrating keratoplasty was the most common proce-
dure with a rate of 32.5%, which was similar with our 
clinic’s previous study (33.1%)(1).
In this study, among the patients who underwent pri-
mary penetrating keratoplasty due to CCO, 76.9% had 
Peters anomaly, followed by 7.7% with glaucoma and 
7.7% with sclerocornea. Central corneal opacity was the 
most common finding with a rate of 78.1% in eyes with 
Peters anomaly. The full thickness of the central corneal 
pathology results in higher rates of penetrating kerato-
plasty in these patients as compared to other diseases. 
In studies of pediatric penetrating keratoplasty, where 
Peters anomaly was observed in majority of patients, 
clear graft at the final visit was found in 29-75.1%(6-13). 
Clear grafts were noted in 66.7% in the previous study 
(mean follow-up time, 33.1 months) from our clinic(1) 
and 76.0% at the last visit in this study (mean follow-up 
time, 26.7 months). When analyzing 6 eyes with graft 
failure, 4 had Peters anomaly (20 in total) and two had 
sclerocornea (2 in total). The graft failure rate was 20% 
in patients with Peters anomaly and 100% in those with 
sclerocornea. Previous studies showed that graft fai-
lure rates were also higher in sclerocornea as compared 
to other CCO etiologies(1,13,14). While sclerocornea was 
previously considered a separate and distinct diagnosis, 
several pediatric ophthalmologists now consider it as an 
(often severe) manifestation of various other conditions, 
most commonly Peters anomaly and Axenfeld-Rieger 
anomaly(15).
In this study, additional interventions during PK 
were moderately positively correlated with graft failure. 
In other studies in the literature, complicated cases 
requiring additional interventions also had worse prog-
nosis(9,12). Glaucoma was the most common pre- and 
pos toperative complicating factors(1,9,10,12). Glaucoma 
history was also moderately positively correlated with 
his tory of previous surgery before performing primary 
ke ratoplasty in this study. Since glaucoma control is 
critically important for graft survival and to maintain 
vision, the more eye surgeries performed, the poorer the 
long-term prognosis is for the graft.
In conclusion, although Peters anomaly remains 
the most common presenting etiology for CCO, its rate 
appears to be increasing in the recent decade. CCO due 
to birth trauma, which is one of the preventable causes, 
was observed in our clinic’s previous study; however, 
no new cases were observed in this study. Although 
idiopathic CCO was observed in our clinic’s previous 
study, its rate appears to be decreasing in the recent 
decade. Although CCO is rare in most clinical practice, 
early diagnosis and management is deemed necessary to 
decrease the risk of lifelong visual problems. However, 
we believe that knowing the success rates of kerato-
plasty for CCO is also important so that patients and 
their caregivers can be prepared to face this condition 
by understanding the usual complications and possible 
re-operations to realize their expectations about the fi-
nal visual outcomes and their quality of life in the future.
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